Singapore markets close in 6 hours 58 minutes
Straits Times Index
3,262.55 -30.58 (-0.93%) Nikkei
37,878.19 -581.89 (-1.51%) Hang Seng
17,129.81 -71.46 (-0.42%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,071.52 -2,711.87 (-4.06%) CMC Crypto 200
1,392.23 -31.87 (-2.24%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 586.35M |
| Enterprise value | 103.30M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.44k |
| Price/book (mrq) | 0.90 |
| Enterprise value/revenue | 794.60 |
| Enterprise value/EBITDA | -0.46 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.56 |
| 52-week change 3 | 17.95% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 3.9700 |
| 52-week low 3 | 1.3200 |
| 50-day moving average 3 | 2.3052 |
| 200-day moving average 3 | 2.1033 |
Share statistics
| Avg vol (3-month) 3 | 922.21k |
| Avg vol (10-day) 3 | 1.23M |
| Shares outstanding 5 | 254.94M |
| Implied shares outstanding 6 | 270.46M |
| Float 8 | 163.35M |
| % held by insiders 1 | 15.59% |
| % held by institutions 1 | 72.93% |
| Shares short (28 Mar 2024) 4 | 18.1M |
| Short ratio (28 Mar 2024) 4 | 20.43 |
| Short % of float (28 Mar 2024) 4 | 10.15% |
| Short % of shares outstanding (28 Mar 2024) 4 | 7.12% |
| Shares short (prior month 29 Feb 2024) 4 | 10.95M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -454,392.33% |
Management effectiveness
| Return on assets (ttm) | -18.18% |
| Return on equity (ttm) | -31.53% |
Income statement
| Revenue (ttm) | 130k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -100.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -225.25M |
| Net income avi to common (ttm) | -234.63M |
| Diluted EPS (ttm) | -0.8800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 546.22M |
| Total cash per share (mrq) | 2.15 |
| Total debt (mrq) | 63.17M |
| Total debt/equity (mrq) | 9.65% |
| Current ratio (mrq) | 16.07 |
| Book value per share (mrq) | 2.58 |
Cash flow statement
| Operating cash flow (ttm) | -163.69M |
| Levered free cash flow (ttm) | -90.36M |
© 2024 Yahoo. All rights reserved.